Menu Search
Equities

CME Group Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MX4A:HAN

CME Group Inc

Actions
  • Price (EUR)232.35
  • Today's Change-0.50 / -0.21%
  • Shares traded10.00
  • 1 Year change+29.16%
  • Beta0.4638
Data delayed at least 15 minutes, as of Jul 04 2025 16:25 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CME Group Inc. provides a derivatives marketplace. The Company enables clients to trade futures, options, cash and over the counter (OTC) markets, optimize portfolios, and analyze data. It exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural products and metals. It offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it operates central counterparty clearing provider, CME Clearing. Its products provide a means for hedging, speculation and asset allocation related to the risks associated with, among other things, interest rate sensitive instruments, and changes in the prices of agricultural, energy and metal commodities. It provides clearing and settlement services for a range of exchange-traded futures and options on futures contracts and OTC derivatives.

  • Revenue in USD (TTM)10.19bn
  • Net income in USD3.58bn
  • Incorporated2001
  • Employees3.76k
  • Location
    CME Group Inc20 S. Wacker Dr.CHICAGO 60606United StatesUSA
  • Phone+1 (312) 930-1000
  • Fax+1 (302) 655-5049
  • Websitehttps://www.cmegroup.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.